ISSN 1662-4009 (online)

ey0015.1-5 | New mechanisms | ESPEYB15

1.5 NOTCH activity differentially affects alternative cell fate acquisition and maintenance

L Cheung , P Le Tissier , SG Goldsmith , M Treier , R Lovell-Badge , K Rizzoti

To read the full abstract: Elife 2018;7. pii: e33318Here, Cheung et al. use sophisticated tissue specific genetic ablation in pituitary cell lineages to uncover an unexpected differential sensitivity of NOTCH activation signalling pathway in different cell lineages during the embryonic murine pituitary development. These findings are important as they further demonstrate the importance of NOTCH pat...

ey0015.9-2 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15

9.2 Anthropometry in Long-Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence

L Collins , L Beaumont , A Cranston , S Savoie , T Nayiager , R Barr

To read the full abstract: J Adolesc Young Adult Oncol. 2017;6:294-298The difficulties in defining obesity in childhood cancer survivors have been emphasised. In these patients, body mass index (BMI) has been confirmed to be a poor predictor of body fatness, because of their impaired linear growth, body composition changes (decreased lean mass and fat redistribution) and abdominal adiposity. Th...

ey0015.9-13 | Biologic agents in chronic inflammatory diseases: lights and shadows | ESPEYB15

9.13 Biologic agents are associated with excessive weight gain in children with inflammatory bowel disease

L Haas , R Chevalier , BT Major , F Enders , S Kumar , J Tung

To read the full abstract: Dig Dis Sci. 2017;62:3110-3116This retrospective single-centre study is the first to report the impact of anti-tumor necrosis factor (anti-TNF) therapy on weight gain in children with inflammatory bowel disease (IBD). The results are consistent with data in adults, in whom weight gain during anti-TNF treatment was negatively correlated to pre-treatment BMI (1). A si...

ey0015.11-2 | New insight into obesity comorbidities | ESPEYB15

11.2 Impact of severe obesity on cardiovascular risk factors in youth

G Zabarsky , C Beek , E Hagman , B Pierpoint , S Caprio , R Weiss

To read the full abstract: Journal of Pediatrics 2018;192:105-114Rising degree of obesity has been shown to predict increased metabolic risk in obese children and adolescents (1). Nonetheless, it is unclear if BMI categories can be successfully applied to populations of obese children and adolescents for a risk-adapted stratification of therapeutic approaches, and here especially for the in...

ey0015.13-7 | How does paediatric endocrinology and diabetes fit in the global initiatives? | ESPEYB15

13.7 Delivering modern, high-quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to action

S Horton , R Sullivan , J Flanigan , KA Fleming , MA Kuti , LM Looi , SA Pai , M Lawler

To read the full abstract: Lancet 2018; 391(10133):1953-1964[Comment on 13.5, 13.6 & 13.7] Published just a week before the World Health Organization put out their first Essential Diagnostics List (http://www.who.int/medical_devices/diagnostics/WHO_EDL_2018.pdf), this series of 3 papers highlights the previo...

ey0015.13-10 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15

13.10 Diabetes in sub-Saharan Africa: from clinical care to health policy

R Atun , JI Davies , EAM Gale , T Barnighausen , D Beran , AP Kengne

To read the full abstract: Lancet Diabetes Endocrinol 2017; 5(8):622-667The Lancet Diabetes and Endocrinology Commission provides a comprehensive, evidence-based review of diabetes in sub-Saharan Africa, one of the most important emerging diseases and markers of the global epidemic of non-communicable diseases. The authors provide a detailed analysis of the significant knowledge gaps in t...

ey0015.13-13 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15

13.13 High Rates of Ocular Complications in a Cohort of Haitian Children and Adolescents with Diabetes

ME Robinson , K Altenor , C Carpenter , R Bonnell , E Jean-Baptiste , J von Oettingen

To read the full abstract: Pediatr Diabetes 2018; 19: (6) 1124In this cross-sectional study performed in Haiti, the authors found that 18% of the children and adolescents with diabetes had signs of retinopathy and that 16% had a cataract. This prevalence is clearly much higher than reported in young patients with diabetes living in high-income countries. Importantly, ocular complications occurred ea...

ey0015.13-14 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15

13.14 Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis

E Wheeler , A Leong , CT Liu , MF Hievert , R Strawbridge , C Podmore

This GWAS meta-analysis combined data from five well known ethnically diverse cohorts (Framingham Heart Study, Atherosclerosis Risk in Communities Study, Multiethnic Study of Atherosclerosis, Taiwan-Metabochip Study for Cardiovascular Disease, and Singapore Prospective Study) to evaluate glycemic and erythrocytic genetic variants impacting HbA1c in individuals of European, African American, and East Asians ancestry. The study found new and known glycemic and...

ey0015.14-2 | And why do women live longer? | ESPEYB15

14.2 Women live longer than men even during severe famines and epidemics

V Zarulli , JA Barthold Jones , A Oksuzyan , R Lindahl-Jacobsen , K Christensen , JW Vaupel

To read the full abstract: Proc Natl Acad Sci U S A 2018;115:E832-E840Women live longer than men in nearly all modern populations. They can expect to live longer than men almost anywhere in the world. This pervasive inequality has intrigued researchers for decades, and many conclude that the gap has biological foundations, which are modulated by social and environmental conditions.<p class=...

ey0015.14-12 | The ‘nocebo’ effect: psychogenic but truly harmful | ESPEYB15

14.12 Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

A Gupta , D Thompson , A Whitehouse , T Collier , B Dahlof , N Poulter , R Collins , P Sever , Investigators ASCOT

To read the full abstract: Lancet 2017;389:2473-2481We are all familiar with the ‘placebo’ effect, when the psychological anticipation of a ‘benefit’ of treatment is so strong that it adds to or even outweighs the actual physical benefits. Many doctors have even admitted to prescribing placebo tablets, or “sugar pills” to their patients, for exam...